Yu Mikami

2.5k total citations · 1 hit paper
49 papers, 1.0k citations indexed

About

Yu Mikami is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Yu Mikami has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Yu Mikami's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Neonatal Respiratory Health Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Yu Mikami is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers), Neonatal Respiratory Health Research (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Yu Mikami collaborates with scholars based in Japan, United States and Sweden. Yu Mikami's co-authors include Takahide Nagase, Masafumi Horie, Akira Saito, Satoshi Noguchi, Yasuhiro Yamauchi, Naoya Miyashita, Richard C. Boucher, Tadashi Kohyama, Mitsuhiro Ohshima and Vishwaraj Sontake and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Oncogene.

In The Last Decade

Yu Mikami

44 papers receiving 987 citations

Hit Papers

Human Lung Stem Cell-Based Alveolospheres Provide Insight... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction
    2020 248 citations Hiroaki Katsura, Vishwaraj Sontake et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Mikami Japan 16 357 342 183 170 155 49 1.0k
Min‐Kyung Yeo South Korea 20 458 1.3× 266 0.8× 222 1.2× 180 1.1× 303 2.0× 94 1.3k
Xiaoming Liu China 19 333 0.9× 172 0.5× 82 0.4× 237 1.4× 85 0.5× 77 1.0k
Edward Carter United Kingdom 17 436 1.2× 176 0.5× 98 0.5× 81 0.5× 168 1.1× 54 956
Chong Lu China 22 571 1.6× 255 0.7× 70 0.4× 190 1.1× 268 1.7× 56 1.2k
Raúl Vivar Chile 19 389 1.1× 89 0.3× 117 0.6× 152 0.9× 98 0.6× 42 937
Qingting Wang China 17 383 1.1× 293 0.9× 61 0.3× 78 0.5× 59 0.4× 50 803
Juan Qian China 21 344 1.0× 99 0.3× 93 0.5× 193 1.1× 183 1.2× 33 1.0k
Csilla Páska Hungary 16 408 1.1× 226 0.7× 90 0.5× 103 0.6× 156 1.0× 27 1.1k
Nobumi Suzuki Japan 16 303 0.8× 146 0.4× 87 0.5× 311 1.8× 216 1.4× 49 806

Countries citing papers authored by Yu Mikami

Since Specialization
Citations

This map shows the geographic impact of Yu Mikami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Mikami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Mikami more than expected).

Fields of papers citing papers by Yu Mikami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Mikami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Mikami. The network helps show where Yu Mikami may publish in the future.

Co-authorship network of co-authors of Yu Mikami

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Mikami. A scholar is included among the top collaborators of Yu Mikami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Mikami. Yu Mikami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Minako, Naoya Miyashita, Takashi Ishii, et al.. (2025). Sirtuin 3 deficiency exacerbates emphysema and lung inflammation in a murine model of chronic obstructive pulmonary disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 329(2). L200–L213. 1 indexed citations
2.
Nakai, Toshiyuki, Sayaka Tanaka, Kanako Sato, et al.. (2025). Application of endobronchial ultrasound-guided cryobiopsy for centrally located intrapulmonary lesions: A retrospective cohort study. Lung Cancer. 205. 108636–108636.
3.
Mikami, Yu, Midori Sato, Hiroyuki Nagai, et al.. (2025). Olaparib-induced interstitial lung disease: A case series analysis. Respiratory Investigation. 63(4). 629–632.
4.
Saito, Akira, Yasuhiro Terasaki, Yu Mikami, et al.. (2025). Integrative epigenome and transcriptome analyses reveal transcriptional programs differentially regulated by ASCL1 and NEUROD1 in small cell lung cancer. Oncogene. 44(34). 3113–3125. 1 indexed citations
5.
6.
Sato, Masakazu, Yu Mikami, Y Miyamoto, et al.. (2023). Clinical Course and Typical Chest CT Findings of Olaparib-induced Lung Injury: A Case Series. A6665–A6665.
7.
Mikami, Yu, Hideo Shindou, Tomoyuki Suzuki, et al.. (2022). Lysophosphatidylcholine Acyltransferase 1 Deficiency Promotes Pulmonary Emphysema via Apoptosis of Alveolar Epithelial Cells. Inflammation. 45(4). 1765–1779. 13 indexed citations
8.
Miyashita, Naoya, Masafumi Horie, Yu Mikami, et al.. (2020). ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma. Cancer Letters. 489. 121–132. 10 indexed citations
9.
Miyashita, Naoya, Masafumi Horie, Hiroshi Suzuki, et al.. (2020). FOXL1 Regulates Lung Fibroblast Function Via Multiple Mechanisms. American Journal of Respiratory Cell and Molecular Biology. 63(6). 831–842. 25 indexed citations
10.
Saito, Minako, Akihisa Mitani, Naoya Miyashita, et al.. (2020). Active mTOR in Lung Epithelium Promotes Epithelial–Mesenchymal Transition and Enhances Lung Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 62(6). 699–708. 30 indexed citations
11.
Katsura, Hiroaki, Vishwaraj Sontake, Aleksandra Tata, et al.. (2020). Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction. Cell stem cell. 27(6). 890–904.e8. 248 indexed citations breakdown →
12.
Mitani, Akihisa, Yu Mikami, Minoru Horie, et al.. (2019). Epithelial Expression of YAP and TAZ Is Sequentially Required in Lung Development. American Journal of Respiratory Cell and Molecular Biology. 62(2). 256–266. 39 indexed citations
13.
Makita, Kosuke, Yu Mikami, Hirotaka Matsuzaki, et al.. (2018). Mechanism of Periostin Production in Human Bronchial Smooth Muscle Cells. International Archives of Allergy and Immunology. 175(1-2). 26–35. 11 indexed citations
14.
Horie, Masafumi, Bogumił Kaczkowski, Mitsuhiro Ohshima, et al.. (2017). Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC. Molecular Cancer Research. 15(10). 1354–1365. 24 indexed citations
15.
16.
Noguchi, Satoshi, Akira Saito, Masafumi Horie, et al.. (2014). An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non–Small Cell Lung Cancer. Clinical Cancer Research. 20(17). 4660–4672. 77 indexed citations
17.
Horie, Minoru, Akira Saito, Yasuhiro Yamauchi, et al.. (2014). Histamine induces human lung fibroblast-mediated collagen gel contraction via histamine H1 receptor. Experimental Lung Research. 40(5). 222–236. 18 indexed citations
18.
Horie, Masafumi, Akira Saito, Yu Mikami, et al.. (2012). Characterization of human lung cancer-associated fibroblasts in three-dimensional in vitro co-culture model. Biochemical and Biophysical Research Communications. 423(1). 158–163. 76 indexed citations
19.
Mikami, Yu, Toshinori Murayama, Masayuki Yokode, et al.. (2010). Atherosclerotic plaques induced by marble-burying behavior are stabilized by exercise training in experimental atherosclerosis. International Journal of Cardiology. 151(3). 284–289. 15 indexed citations
20.
Takahashi, M, Shuhei Ota, Y. Hata, et al.. (1996). Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach.. Journal of Clinical Investigation. 98(11). 2604–2611. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min‐Kyung Yeo Breakdown of academic impact, for papers by Xiaoming Liu Breakdown of academic impact, for papers by Edward Carter Breakdown of academic impact, for papers by Chong Lu Breakdown of academic impact, for papers by Raúl Vivar Breakdown of academic impact, for papers by Qingting Wang Breakdown of academic impact, for papers by Juan Qian Breakdown of academic impact, for papers by Csilla Páska Breakdown of academic impact, for papers by Nobumi Suzuki
Rankless by CCL
2026